These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24396453)

  • 41. Surface PEGylated Cancer Cell Membrane-Coated Nanoparticles for Codelivery of Curcumin and Doxorubicin for the Treatment of Multidrug Resistant Esophageal Carcinoma.
    Gao Y; Zhu Y; Xu X; Wang F; Shen W; Leng X; Zhao J; Liu B; Wang Y; Liu P
    Front Cell Dev Biol; 2021; 9():688070. PubMed ID: 34386493
    [TBL] [Abstract][Full Text] [Related]  

  • 42. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
    Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
    Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of cyclosporin A on intracellular accumulation and efflux of drug in K562/DOX cells].
    Meng H; Lin X; Lin M
    Zhonghua Xue Ye Xue Za Zhi; 1997 May; 18(5):254-6. PubMed ID: 15622758
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Selective anticancer activity of hydroxyapatite/chitosan-poly(d,l)-lactide-co-glycolide particles loaded with an androstane-based cancer inhibitor.
    Ignjatović NL; Penov-Gaši KM; Wu VM; Ajduković JJ; Kojić VV; Vasiljević-Radović D; Kuzmanović M; Uskoković V; Uskoković DP
    Colloids Surf B Biointerfaces; 2016 Dec; 148():629-639. PubMed ID: 27694053
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Susceptibility of nanoparticle-encapsulated paclitaxel to P-glycoprotein-mediated drug efflux.
    Chavanpatil MD; Patil Y; Panyam J
    Int J Pharm; 2006 Aug; 320(1-2):150-6. PubMed ID: 16713148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance.
    Zhao Y; Huan ML; Liu M; Cheng Y; Sun Y; Cui H; Liu DZ; Mei QB; Zhou SY
    Sci Rep; 2016 Oct; 6():35267. PubMed ID: 27731405
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TPGS2k/PLGA nanoparticles for overcoming multidrug resistance by interfering mitochondria of human alveolar adenocarcinoma cells.
    Wang DF; Rong WT; Lu Y; Hou J; Qi SS; Xiao Q; Zhang J; You J; Yu SQ; Xu Q
    ACS Appl Mater Interfaces; 2015 Feb; 7(7):3888-901. PubMed ID: 25644220
    [TBL] [Abstract][Full Text] [Related]  

  • 51. PLGA-PEG nanoparticles for targeted delivery of the mTOR/PI3kinase inhibitor dactolisib to inflamed endothelium.
    Gholizadeh S; Kamps JAAM; Hennink WE; Kok RJ
    Int J Pharm; 2018 Sep; 548(2):747-758. PubMed ID: 29042337
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-encapsulation of magnetic Fe
    Liang C; Li N; Cai Z; Liang R; Zheng X; Deng L; Feng L; Guo R; Wei B
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):4211-4221. PubMed ID: 31713444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled release of doxorubicin from Poly-(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by coaxial electrospraying.
    Liu Y; Craig DQM; Parhizkar M
    Int J Pharm; 2024 Dec; 666():124724. PubMed ID: 39312984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
    Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
    Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
    Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
    Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible contribution of sialic acid to the enhanced tumor targeting efficiency of nanoparticles engineered with doxorubicin.
    Lee SY; Nam S; Koo JS; Kim S; Yang M; Jeong DI; Hwang C; Park J; Cho HJ
    Sci Rep; 2020 Nov; 10(1):19738. PubMed ID: 33184416
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein.
    Chandra S; Michael Nguyen H; Wiltz K; Hall N; Chaudhry S; Olverson G; Mandal T; Dash S; Kundu A
    J Cancer Treatment Diagn; 2020; 4(1):1-13. PubMed ID: 32395707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development and optimization of doxorubicin loaded poly(lactic-co-glycolic acid) nanobubbles for drug delivery into HeLa cells.
    Deng L; Li L; Yang H; Li L; Zhao F; Wu C; Liu Y
    J Nanosci Nanotechnol; 2014 Apr; 14(4):2947-54. PubMed ID: 24734715
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DOX-loaded PEG-PLGA and Pluronic copolymer composite micelles enhances cytotoxicity and the intracellular accumulation of drug in DOX-resistant tumor cells.
    Diao YY; Han M; Ding PT; Chen DW; Gao JQ
    Pharmazie; 2010 May; 65(5):356-8. PubMed ID: 20503928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.